tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Terence Flynn, 248 are a HOLD (46.62%), 43 are a SELL (8.08%), 241 are a BUY (45.3%).
Analyst Terence Flynn, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 70.71% that have a potential upside of 24.93% achieved within 259 days. Previously, Terence Flynn worked at GOLDMAN SACHS.
Terence Flynn’s has documented 1,067 price targets and ratings displayed on 44 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMGN, Amgen at 04-Nov-2026.
Analyst best performing recommendations are on XLRN (ACCELERON PHARMA).
The best stock recommendation documented was for XLRN (ACCELERON PHARMA) at 3/22/2021. The price target of $132 was fulfilled within 2 days with a profit of $11.64 (8.1%) receiving and performance score of 40.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Oct-2025
$57
$11.1 (24.18%)
$56
7 days ago
(04-Nov-2026)
8/11 (72.73%)
$11.11 (24.21%)
304
Buy Since 03-Sep-2025
$68
$22.1 (48.15%)
$65
7 days ago
(04-Nov-2026)
5/7 (71.43%)
$22.11 (48.18%)
161
Hold Since 26-Oct-2017
$50
$4.1 (8.93%)
$43
7 days ago
(04-Nov-2026)
28/29 (96.55%)
$4.11 (8.96%)
341
Buy Since 16-Oct-2026
$55
$9.1 (19.83%)
$21
26 days ago
(16-Oct-2026)
7/8 (87.5%)
$13.78 (33.43%)
880
Hold Since 24-Sep-2026
$50
$4.1 (8.93%)
$43
1 months 18 days ago
(24-Sep-2026)
1/2 (50%)
$9.21 (22.58%)
324
Which stock is Terence Flynn most bullish on?
Which stock is Terence Flynn most reserved on?
What Year was the first public recommendation made by Terence Flynn?
